A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers

NCT06675565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ALN-AGT01 RVR
DRUG: Placebo

Sponsor

Alnylam Pharmaceuticals